Springboard Health Nutrition notebook Health information
Health Problems  pixels Return home
2 pixels

Hypercoagulation & Heparin A Second Look

Read these related articles
Hypercoagulation Linked to Chronic Fatigue, Fibromyalgia, MS, Infertility, Chronic Illness - PART 1
Hypercoagulation Linked to Chronic Fatigue, Fibromyalgia, MS, Infertility, Chronic Illness - PART 2

Patricia Kane, Ph.D.

It has been suggested that the use of heparin will address hypercoagulation. Recent data from JAMA1 indicates that the use of low dose heparin may transform a ‘benign fungal infection into a toxic shock-like reaction’.

This research was presented at the 39th annual meeting of the Infectious Diseases Society of America in 2001 by Margaret K. Hostetter, M.D.2, 3 of Yale University School of Medicine. Hostetter and colleagues found that Candida albicans can attach to host cells and form invasive hyphae which ultimately may create virulence of C. albicans.

Low dose heparin utilized in hospitalized patients through the practice of heparin in intravascular catheters may transform the yeast into a life threatening pathogen1. The use of heparin raises the cytokines TNF alpha1 and IL-6 1 in addition to Phospholipase A 2 .4, 5, 6. Biotoxins which form neurotoxins, may create a state of hypercoagulation from the rise in TNF alpha.

Consequently, the use of heparin may exacerbate the neurotoxic condition and hypercoagulation.


1. Stephenson J. Can a Common Medical Practice Transform Candida Infections from Benign to Deadly? JAMA286:20: Nov 28, 2001.

2. Hostetter MK. Fungal infections in the neonatal intensive care. Semin Pediatr Infect Dis 12(4); 296-300, Oct 2001.

3. San-Blas G, et al. Fungal morphogenesis and virulence. Med Mycol 38 Suppl 1:79-86, 2000.

4. Mudher AK, et al. Heparin injection into the adult rat hippocampus induces seizures in the absence of macroscopic abnormalities. Neuroscience 89:2:329-333, Mar 1, 1999.

5. Kern H, et al. Heparin induces release of phospholipase A2 into the splanchnic circulation. Anesth Analg 91:3:528-532: Sept 2000.

6. Farooqui AA, et al. Inhibitors of intracellular phospholipase A2 activity: Their neurochemical effects and therapeutic importance of neurological disorders. Brain Res Bull 49:3:139-153, June 1999.

Click here for product availability

296 pixels

Return to top

Copyright © 2007 Springboard All rights reserved.
2 pixels
Left tab 436 Pixels Right tab